Hello and welcome to the details of Thai-developed Covid-19 vaccine starts human trials and now with the details
Subscribe to our Telegram channel for the latest updates on news you need to know.
BANGKOK, March 22 —Thailand started human trials today of a domestically developed coronavirus vaccine and expects to deploy it next year, which its health minister said could give the country more freedom with its vaccine policy.
Thailand’s vaccination drive is targeting the inoculation of half of its adult population by the end of the year using 61 million doses of AstraZeneca’s vaccine, which will be locally produced from June.
The home-grown vaccine candidate is being developed by state drug maker, the Government Pharmaceutical Organization (GPO), with Mahidol University’s Tropical Medicine Department and an American non-profit and uses an inactivated virus to trigger immunity.
“The vaccine, produced by Thais for Thais, is expected to be used next year,” Piyasakol Sakolsatayadorn, chairman of the Mahidol University Council, told a news conference.
Thailand’s progress comes as countries including Japan and Taiwan speed up domestic vaccine development programmes amid tight global supply and concerns about new Covid-19 variants.
Vietnam last week said its locally developed vaccine would be available by the fourth quarter of this year.
Mahidol University’s dean, Bangjong Mahaisavariya, said 460 volunteers would be accepted for the human trials, 210 of whom would be used in the first phase. Phase two is expected to begin in July, with results by year-end.
The Thai vaccine candidate modifies the avian Newcastle Disease virus with a Covid-19 spike protein and is replicated using egg-based technology, the GPO said.
Health Minister Anutin Charnvirakul said the vaccine would give Thailand more options with less constraints.
“Even though we can produce vaccines in the country, it is from technology transfer and under management of brands,” he told the news conference.
“But today, if we are successful we can set our own direction.”
Another homegrown vaccine is being developed by Chulalongkorn University and uses Messenger RNA (mRNA) technology. It is expected to start human trials soon.
Thailand has recorded 27,876 coronavirus cases in total, with 91 deaths. — Reuters
These were the details of the news Thai-developed Covid-19 vaccine starts human trials for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at Malay Mail and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.